Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
Fibronectins Connect Cells with ECM01:25

Fibronectins Connect Cells with ECM

Fibronectin is an adhesive glycoprotein present in the extracellular matrix of embryogenic and adult tissue. These molecules primarily aid in regulating cell motility and attachment. A fibronectin molecule is composed of two identical polypeptide chains attached to each other by a pair of disulfide bonds at the C-terminal.
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Crosstalk of the Hippo/YAP pathway in the progression of oral potentially malignant disorders to oral squamous cell carcinoma: a systematic review.

Frontiers in oral health·2026
Same author

SYISL promotes pulmonary epithelial-mesenchymal transition and fibrosis through DSP-Hippo/YAP pathway.

Cellular and molecular life sciences : CMLS·2026
Same author

A Pan-Cancer Transcriptomic Signature for Conserved Molecular Programs Underlying Premalignant-Malignant Progression Across Common Carcinomas.

Dentistry journal·2026
Same author

CCN1: a SASPy protein that plays multifaceted roles in fibrogenesis.

Matrix biology : journal of the International Society for Matrix Biology·2025
Same author

The Areca Nut and Oral Submucosal Fibrosis: A Narrative Review.

Dentistry journal·2025
Same author

George R. Martin: Pioneering matrix biologist.

Matrix biology : journal of the International Society for Matrix Biology·2025
Same journal

Ceramide-mediated mitochondrial dysfunction in nonobese nonalcoholic fatty liver disease: A regulatory role for serine palmitoyltransferase subunit 2.

Journal of cell communication and signaling·2026
Same journal

Correction to Regulation of phosphatase and tensin homolog by complement component 5a (C5a) and its receptor (C5aR 1) in lupus nephritis: A novel therapeutic target.

Journal of cell communication and signaling·2026
Same journal

Plasma exosomal miR-339-3p promotes myocardial remodeling in chronic heart failure by regulating USP25-mediated DDX58 deubiquitination.

Journal of cell communication and signaling·2026
Same journal

A working model for CCN3 C-terminal domain-mediated transcriptional modulation of the plasminogen activation system.

Journal of cell communication and signaling·2026
Same journal

Inflammatory cytokine IL-6 regulates ADAMTS14 expression through MAPK and PI3K signaling in colorectal cancer.

Journal of cell communication and signaling·2026
Same journal

Gemcitabine activates the Hippo signaling pathway and suppresses tumor growth by stabilizing large tumor suppressor kinase 2 through the hypoxia-inducible factor 1-alpha/ubiquitin protein ligase E3 component N-recognin 5 axis.

Journal of cell communication and signaling·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

Fibroblast Derived Human Engineered Connective Tissue for Screening Applications
09:50

Fibroblast Derived Human Engineered Connective Tissue for Screening Applications

Published on: August 20, 2021

Eureka! Ets a target for fibrosis!

Andrew Leask1

  • 1Department of Dentistry, Dental Sciences Building, University of Western Ontario, London, ON, Canada, N6A 5C1, Andrew.leask@schulich.uwo.ca.

Journal of Cell Communication and Signaling
|July 13, 2011
PubMed
Summary
This summary is machine-generated.

Phosphorylation of the Ets2 transcription factor is crucial for developing lung fibrosis. Mice lacking this phosphorylation were resistant to bleomycin-induced fibrosis, highlighting Ets2

More Related Videos

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
06:02

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition

Published on: June 10, 2016

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies
06:46

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies

Published on: February 15, 2019

Related Experiment Videos

Last Updated: May 31, 2026

Fibroblast Derived Human Engineered Connective Tissue for Screening Applications
09:50

Fibroblast Derived Human Engineered Connective Tissue for Screening Applications

Published on: August 20, 2021

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition
06:02

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition

Published on: June 10, 2016

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies
06:46

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies

Published on: February 15, 2019

Area of Science:

  • Molecular biology
  • Cellular biology
  • Fibrosis research

Background:

  • The Ets family of transcription factors regulates pro-fibrotic genes in fibroblasts.
  • Transforming growth factor β (TGF-β) induces CCN2 expression via Ets factors.
  • Lung fibrosis is a significant health concern with complex molecular underpinnings.

Purpose of the Study:

  • To comment on the findings regarding the role of Ets2 phosphorylation in lung fibrosis.
  • To highlight the significance of Baran et al.'s study on ets2 phosphorylation and fibrosis resistance.

Main Methods:

  • The commentary discusses findings from a study involving genetically modified mice.
  • The study utilized bleomycin-induced lung fibrosis as a model.
  • The key manipulation involved a non-phosphorylatable version of the ets2 gene.

Main Results:

  • Mice expressing a non-phosphorylatable ets2 were resistant to bleomycin-induced lung fibrosis.
  • This suggests that the phosphorylation status of Ets2 is critical for fibrosis development.
  • The study implicates Ets2 in the fibrotic response pathway.

Conclusions:

  • Ets2 phosphorylation is a key event in the pathogenesis of lung fibrosis.
  • Targeting Ets2 phosphorylation may offer a therapeutic strategy for treating fibrotic lung diseases.
  • Further research into the molecular mechanisms of Ets2 in fibrosis is warranted.